Mylan To Pay $465 Million Over EpiPen Medicaid Rebate Classification Mylan has agreed to pay $465 million after lawmakers and health officials said it wrongly classified EpiPen as a generic product. The classification allowed the pharmaceutical company to pay lower rebates for Medicaid program. by Rhodi Lee
Health Vegan Mom Who Fed 11-Month-Old Baby Nuts And Berries Charged For Child Endangerment by Rhodi Lee
Health AFM: Possible Causes And Symptoms Of Polio-Like Disease Causing Paralysis In US Children by Rhodi Lee
Health Insulin Pump Vulnerable To Cyberattack: Hackers May Exploit Device To Overdose Diabetic Patients With Insulin, J&J Warns by Rhodi Lee
Health Polio-Like Disease That Paralyzes Children On The Rise In The US: How To Protect Kids From Acute Flaccid Myelitis by Rhodi Lee
Health 2016 Nobel Prize Winner Yoshinori Ohsumi's Work On Cellular Recycling May Change How We Treat Cancer, Other Diseases by Rhodi Lee
Science Bees Among 49 Plant And Animal Species In Hawaii Added To Endangered Species List by Rhodi Lee
Science Sauropod Footprint Found In Mongolian Desert Is Largest Dinosaur Footprint Ever Found by Rhodi Lee
Science Rare Tree Frog Species Likely Extinct After Last Known Living Member Dies At Atlanta Botanical Garden by Rhodi Lee